We are live on ! Find out more
GGHC

Gilder Gagnon Howe & Co Portfolio holdings

AUM $9.69B
1-Year Est. Return 55.7%
This Fund
S&P 500
This Quarter Est. Return
+13.03%
1 Year Est. Return
+55.7%
3 Year Est. Return
+243.5%
5 Year Est. Return
+259.56%
10 Year Est. Return
+4,571.41%
AUM
$5.73B
AUM Growth
+$122M
Cap. Flow
-$305M
Cap. Flow %
-5.31%
Top 10 Hldgs %
36.62%
Holding
266
New
17
Increased
50
Reduced
179
Closed
19

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$54.5M
2
NVO
Novo Nordisk
NVO
+$53.8M
3
ABNB icon
Airbnb
ABNB
+$35.5M
4
BNTX icon
BioNTech
BNTX
+$22.3M
5
NVDA icon
NVIDIA
NVDA
+$16.9M

Sector Composition

Rank Sector Weight
1 Technology 32.17%
2 Consumer Discretionary 24.08%
3 Healthcare 19.02%
4 Industrials 8.18%
5 Communication Services 7.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NVSAU
101
DELISTED
New Vista Acquisition Corp Unit
NVSAU
$10.5M 0.18%
1,058,744
-85,572
-7% -$847K
TNDM icon
102
Tandem Diabetes Care
TNDM
$1.17B
$10.3M 0.18%
215,980
-126,493
-37% -$6.93M
INDI icon
103
indie Semiconductor
INDI
$726M
$10.1M 0.18%
+1,375,924
New +$10.2M
ONON icon
104
On Holding
ONON
$9.18B
$9.38M 0.16%
584,314
+38,501
+7% +$768K
HDB icon
105
HDFC Bank
HDB
$118B
$9.32M 0.16%
319,252
-1,132
-0.4% -$34.8K
CDXS icon
106
Codexis
CDXS
$162M
$8.85M 0.15%
1,459,913
-511,431
-26% -$4.11M
TDG icon
107
TransDigm Group
TDG
$61.4B
$8.48M 0.15%
16,167
+43
+0.3% +$25.7K
FNV icon
108
Franco-Nevada
FNV
$51.3B
$8.44M 0.15%
70,640
-32
-0% -$4.02K
RUN icon
109
Sunrun
RUN
$2.01B
$8.38M 0.15%
303,673
-15,364
-5% -$478K
GDX icon
110
VanEck Gold Miners ETF
GDX
$28.3B
$8.13M 0.14%
336,847
-889
-0.3% -$22.5K
SU icon
111
Suncor Energy
SU
$80.4B
$7.99M 0.14%
283,792
-2,334
-0.8% -$73.7K
AZUL
112
DELISTED
Azul
AZUL
$7.83M 0.14%
961,310
-8,315
-0.9% -$70K
ZS icon
113
Zscaler
ZS
$31.3B
$7.8M 0.14%
+47,441
New +$7.76M
WRB icon
114
W.R. Berkley
WRB
$25.9B
$7.77M 0.14%
180,500
+14
+0% +$608
CLFD icon
115
Clearfield
CLFD
$408M
$7.66M 0.13%
73,206
-27,362
-27% -$2.66M
NKE icon
116
Nike
NKE
$55B
$7.46M 0.13%
89,741
-27,320
-23% -$2.94M
SITM icon
117
SiTime
SITM
$16.8B
$7.25M 0.13%
92,130
-8,290
-8% -$1.07M
HEI.A icon
118
HEICO Corp Class A
HEI.A
$31.8B
$7.24M 0.13%
63,158
-52
-0.1% -$6.26K
NARI
119
DELISTED
Inari Medical, Inc. Common Stock
NARI
$6.69M 0.12%
92,154
+2,360
+3% +$176K
PTON icon
120
Peloton Interactive
PTON
$2.17B
$6.55M 0.11%
945,215
-238,737
-20% -$2.43M
DGII icon
121
Digi International
DGII
$2.53B
$6.35M 0.11%
+183,810
New +$5.7M
RCUS icon
122
Arcus Biosciences
RCUS
$3.06B
$6.31M 0.11%
241,227
+19,145
+9% +$506K
PHAT icon
123
Phathom Pharmaceuticals
PHAT
$702M
$6.12M 0.11%
552,442
-3,663
-0.7% -$34.9K
WRBY icon
124
Warby Parker
WRBY
$3.18B
$5.91M 0.1%
+443,201
New +$5.9M
TECK icon
125
Teck Resources
TECK
$32.5B
$5.73M 0.1%
188,318
-11,078
-6% -$342K

Similar funds

Gilder Gagnon Howe & Co's Q3 2022 Portfolio in Review

As of Q3 2022, Gilder Gagnon Howe & Co held 266 positions worth $5.73B, up 2.2% from $5.61B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Gilder Gagnon Howe & Co withdrew a net $305M in Q3 2022, closing 19 positions and reducing 179 holdings. Its most notable exit was 1Life Healthcare, an estimated $23.4M position sold in full.

By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 33% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Gilder Gagnon Howe & Co opened a new position in Novo Nordisk worth $50M.

  • Gilder Gagnon Howe & Co's largest Q3 2022 buy was Novo Nordisk: 1,004,430 shares worth $50M.
  • Gilder Gagnon Howe & Co added most to Eli Lilly in Q3 2022, an estimated $54.5M increase.
  • Gilder Gagnon Howe & Co's biggest Q3 2022 reduction was Shockwave Medical, Inc. Common Stock, cutting an estimated $45.6M.
  • Gilder Gagnon Howe & Co fully exited 1Life Healthcare in Q3 2022, selling an estimated $23.4M.
  • Gilder Gagnon Howe & Co's ten largest holdings make up 37% of its $5.73B portfolio in Q3 2022.
  • Gilder Gagnon Howe & Co opened 17 new positions and closed 19 in Q3 2022.
  • Gilder Gagnon Howe & Co's portfolio value rose 2.2% quarter-over-quarter to $5.73B.

Based on Gilder Gagnon Howe & Co's 13F filing for Q3 2022, filed 14 Nov 2022.